PI Perspective #26

December 1998     View PDF     En español

Expanded Access

These new drugs are currently available free of charge while awaiting final FDA approval.

Amprenavir (PI)
800-248-9757
For anyone tolerate or failing current protease inhibitor therapy and requiring an additional new drug for treatment strategy.

Abacavir (NRTI)
800-501-4672
For anyone failing current therapy and requiring an additional new drug for treatment strategy.

Adefovir (NtRTI)
800-445-3235
For anyone failing current therapy and requiring an additional new drug for treatment strategy.